Jeffrey A Meckler - Net Worth and Insider Trading
Jeffrey A Meckler Net Worth
The estimated net worth of Jeffrey A Meckler is at least $501,610 dollars as of 2024-04-19. Jeffrey A Meckler is the Director of Travere Therapeutics Inc and owns about 52,000 shares of Travere Therapeutics Inc (TVTX) stock worth over $292,500. Jeffrey A Meckler is the CEO and Director of Indaptus Therapeutics Inc and owns about 75,374 shares of Indaptus Therapeutics Inc (INDP) stock worth over $185,420. Jeffrey A Meckler is also the CEO of Intec Parent Inc and owns about 2,460 shares of Intec Parent Inc (NTEC) stock worth over $23,690. Details can be seen in Jeffrey A Meckler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey A Meckler has not made any transactions after 2022-11-21 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey A Meckler
Jeffrey A Meckler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey A Meckler owns 6 companies in total, including Intec Parent Inc (NTEC) , Travere Therapeutics Inc (TVTX) , and Novelion Therapeutics Inc (NVLNF) among others .
Click here to see the complete history of Jeffrey A Meckler’s form 4 insider trades.
Insider Ownership Summary of Jeffrey A Meckler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTEC | Intec Parent Inc | 2020-07-15 | director & Chief Executive Officer |
| TVTX | Travere Therapeutics Inc | 2016-03-04 | director |
| NVLNF | Novelion Therapeutics Inc | 2016-06-17 | director |
| COCP | Cocrystal Pharma Inc | 2014-11-25 | director |
| SRDX | Surmodics Inc | 2010-11-17 | other: See Explanation of Responses |
| INDP | Indaptus Therapeutics Inc | 2022-11-21 | director & Chief Executive Officer |
Jeffrey A Meckler Latest Holdings Summary
Jeffrey A Meckler currently owns a total of 3 stocks. Among these stocks, Jeffrey A Meckler owns 52,000 shares of Travere Therapeutics Inc (TVTX) as of March 4, 2016, with a value of $292,500 and a weighting of 58.31%. Jeffrey A Meckler owns 75,374 shares of Indaptus Therapeutics Inc (INDP) as of November 21, 2022, with a value of $185,420 and a weighting of 36.96%. Jeffrey A Meckler also owns 2,460 shares of Intec Parent Inc (NTEC) as of August 28, 2019, with a value of $23,690 and a weighting of 4.72%.
Latest Holdings of Jeffrey A Meckler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2016-03-04 | 52,000 | 5.63 | 292,500 |
| INDP | Indaptus Therapeutics Inc | 2022-11-21 | 75,374 | 2.46 | 185,420 |
| NTEC | Intec Parent Inc | 2019-08-28 | 2,460 | 9.63 | 23,690 |
Holding Weightings of Jeffrey A Meckler
Jeffrey A Meckler Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey A Meckler has made a total of 0 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years. The most-recent trade in Travere Therapeutics Inc is the acquisition of 5,000 shares on March 4, 2016, which cost Jeffrey A Meckler around $76,550.
According to the SEC Form 4 filings, Jeffrey A Meckler has made a total of 6 transactions in Indaptus Therapeutics Inc (INDP) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Indaptus Therapeutics Inc is the acquisition of 10,000 shares on November 21, 2022, which cost Jeffrey A Meckler around $18,900.
According to the SEC Form 4 filings, Jeffrey A Meckler has made a total of 2 transactions in Intec Parent Inc (NTEC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Intec Parent Inc is the acquisition of 250 shares on August 28, 2019, which cost Jeffrey A Meckler around $13,600.
Insider Trading History of Jeffrey A Meckler
- 1
Jeffrey A Meckler Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey A Meckler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey A Meckler is -7.63%. GuruFocus also compares Jeffrey A Meckler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey A Meckler within 3 months outperforms 2 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey A Meckler's insider trading performs compared to the benchmark.
Performance of Jeffrey A Meckler
Average Return
-11.51%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11 | -7.63 | -27.14 | -11.51 | -2.92 | 14.33 |
| Relative Return to S&P 500(%) | 12.32 | -9.55 | -28.82 | -20.96 | -10.65 | 2.42 |
Jeffrey A Meckler Ownership Network
Ownership Network List of Jeffrey A Meckler
Ownership Network Relation of Jeffrey A Meckler
Jeffrey A Meckler Owned Company Details
What does Intec Parent Inc do?
Who are the key executives at Intec Parent Inc?
Jeffrey A Meckler is the director & Chief Executive Officer of Intec Parent Inc. Other key executives at Intec Parent Inc include Chief Business Officer Walt Addison Linscott , Chief Financial Officer Nir Sassi , and Chief Operating Officer Nadav Navon .
Intec Parent Inc (NTEC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intec Parent Inc (NTEC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intec Parent Inc (NTEC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intec Parent Inc (NTEC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intec Parent Inc Insider Transactions
Jeffrey A Meckler Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey A Meckler. You might contact Jeffrey A Meckler via mailing address: 740 Broadway, 9th Floor, New York Ny 10003.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
